Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma

Objectives: Report the feasibility, toxicities, and long-term results of a Phase I/II trial of (90)Y-labeled anticarcinoembryonic antigen (anti-CEA) (cT84.66) radioimmunotherapy (RIT), gemcitabine, and hepatic arterial infusion (HAI) of fluorodeoxyuridine (FUdR) after maximal hepatic resection of me...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Biother Radiopharm
Glavni autori: Cahan, Benjamin, Leong, Lucille, Wagman, Lawrence, Yamauchi, David, Shibata, Stephen, Wilzcynski, Sharon, Williams, Lawrence E., Yazaki, Paul, Colcher, David, Frankel, Paul, Wu, Anna, Raubitschek, Andrew, Shively, John, Wong, Jeffrey Y.C.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2017
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646801/
https://ncbi.nlm.nih.gov/pubmed/28910150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2017.2223
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items